Related Experiment Videos
Functional characterization and receptor binding studies of the malic enzyme thyroid hormone response element
B Desvergne1, K J Petty, V M Nikodem
1Clinical Endocrinology Branch, National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
The Journal of Biological Chemistry
|January 15, 1991
Summary
Thyroid hormone receptors bind to the malic enzyme gene
Area of Science:
- Molecular Biology
- Genetics
- Endocrinology
Background:
- The 5'-flanking region of the malic enzyme (ME) gene contains a cis-regulatory element that binds thyroid hormone receptors.
- This element confers triiodothyronine (T3)-inducibility of transcription to the ME promoter.
Purpose of the Study:
- To evaluate the roles of subregions within the ME thyroid hormone response element (TRE) in T3 binding and transactivation.
- To elucidate the functional significance of discrete regions within the TRE.
Main Methods:
- Deletion and mutation analyses of the ME TRE.
- Transient expression assays using NIH 3T3 cells and chloramphenicol acetyltransferase reporter gene.
- Competition binding assays to assess receptor binding to wild-type and mutated TRE.
Main Results:
- The ME TRE functions as an enhancer, conferring T3 responsiveness to a heterologous promoter.
- T3 treatment induced promoter activity, while hormone absence resulted in repression.
- Functional TRE regions are discrete and non-contiguous, with a cluster of G residues and an AGGACA sequence playing dominant roles.
- Both transcriptional induction and repression correlated with receptor binding.
Conclusions:
- The ME TRE contains distinct functional subregions critical for thyroid hormone receptor interaction and transcriptional regulation.
- The identified functional regions, including a G-rich cluster and AGGACA sequence, are essential for mediating both T3-induced activation and hormone-dependent repression.
- Receptor binding affinity to the TRE directly correlates with its ability to modulate gene transcription in response to thyroid hormone.